Bax:Bcl2 Cancer Research Results

Bax:Bcl2, Bax:Bcl2 ratio: Click to Expand ⟱
Source:
Type:
Bax and Bcl-2 are the major members of Bcl-2 family that play a key role in tumor progression or inhibition of intrinsic apoptotic pathway triggered by mitochondrial dysfunction.
Bax/Bcl-2 ratio is typically significantly lower in tumors.


Bladder, Bladder Cancer: Click to Expand ⟱
Bladder Cancer

Scientific Papers found: Click to Expand⟱
5551- BBM,    Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis
- vitro+vivo, Bladder, NA
tumCV↓, TumCP↓, TumCCA↑, P21↑, p27/CDKN1B↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK2↓, EMT↓, TumMeta↓, p65↓, p‑p65↓, IKKα↓, NF-kB↑, ROS↑, NRF2↓, HO-1↓, SOD2↓, GPx1↓, Bax:Bcl2↑, TumVol↓,
7252- Gink,    STEAP2-associated modulation of PI3K/AKT/mTOR signaling contributes to ginkgetin-induced apoptosis in bladder cancer cells
- in-vitro, Bladder, 5637 - in-vitro, CRC, T24/HTB-9 - in-vitro, Bladder, J82 - in-vitro, Nor, SV-HUC-1
tumCV↓, selectivity↑, TumCMig↓, EMT↓, p‑PI3K↓, p‑Akt↓, p‑mTOR↓, STEAP3↓, Bax:Bcl2↑, cl‑Casp3↑,
1458- SFN,    Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma
- Review, Bladder, NA
HDAC↓, eff↓, TumW↓, TumW↓, angioG↓, *toxicity↓, GutMicro↝, AntiCan↑, ROS↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, Casp8∅, cl‑PARP↑, TRAIL↑, DR5↑, eff↓, NRF2↑, ER Stress↑, COX2↓, EGFR↓, HER2/EBBR2↓, ChemoSen↑, NF-kB↓, TumCCA?, p‑Akt↓, p‑mTOR↓, p70S6↓, p19↑, P21↑, CD44↓, CSCs↓,
1482- SFN,    Sulforaphane induces apoptosis in T24 human urinary bladder cancer cells through a reactive oxygen species-mediated mitochondrial pathway: the involvement of endoplasmic reticulum stress and the Nrf2 signaling pathway
- in-vitro, Bladder, T24/HTB-9
tumCV↓, Apoptosis↑, Cyt‑c↑, Bax:Bcl2↑, Casp9↑, Casp3↑, Casp8∅, cl‑PARP↑, ROS↑, MMP↓, eff↓, ER Stress↑, p‑NRF2↑, HO-1↑,

Showing Research Papers: 1 to 4 of 4

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

GPx1↓, 1,   HO-1↓, 1,   HO-1↑, 1,   NRF2↓, 1,   NRF2↑, 1,   p‑NRF2↑, 1,   ROS↑, 3,   SOD2↓, 1,  

Metal & Cofactor Biology(tgid=2)

STEAP3↓, 1,  

Mitochondria & Bioenergetics(tgid=3)

MMP↓, 2,  

Cell Death(tgid=5)

p‑Akt↓, 2,   Apoptosis↑, 1,   Bax:Bcl2↑, 4,   Casp3↑, 2,   cl‑Casp3↑, 1,   Casp8∅, 2,   Casp9↑, 2,   Cyt‑c↑, 2,   DR5↑, 1,   p27/CDKN1B↑, 1,   TRAIL↑, 1,  

Kinase & Signal Transduction(tgid=6)

HER2/EBBR2↓, 1,   p70S6↓, 1,  

Transcription & Epigenetics(tgid=7)

tumCV↓, 3,  

Protein Folding & ER Stress(tgid=8)

ER Stress↑, 2,  

DNA Damage & Repair(tgid=10)

cl‑PARP↑, 2,  

Cell Cycle & Senescence(tgid=11)

CDK2↓, 1,   cycA1/CCNA1↓, 1,   cycD1/CCND1↓, 1,   p19↑, 1,   P21↑, 2,   TumCCA?, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

CD44↓, 1,   CSCs↓, 1,   EMT↓, 2,   HDAC↓, 1,   p‑mTOR↓, 2,   p‑PI3K↓, 1,  

Migration(tgid=13)

TumCMig↓, 1,   TumCP↓, 1,   TumMeta↓, 1,  

Angiogenesis & Vasculature(tgid=14)

angioG↓, 1,   EGFR↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

COX2↓, 1,   IKKα↓, 1,   NF-kB↓, 1,   NF-kB↑, 1,   p65↓, 1,   p‑p65↓, 1,  

Drug Metabolism & Resistance(tgid=21)

ChemoSen↑, 1,   eff↓, 3,   selectivity↑, 1,  

Clinical Biomarkers(tgid=22)

EGFR↓, 1,   GutMicro↝, 1,   HER2/EBBR2↓, 1,  

Functional Outcomes(tgid=23)

AntiCan↑, 1,   TumVol↓, 1,   TumW↓, 2,  
Total Targets: 59

Pathway results for Effect on Normal Cells:


Functional Outcomes(tgid=23)

toxicity↓, 1,  
Total Targets: 1

Scientific Paper Hit Count for: Bax:Bcl2, Bax:Bcl2 ratio
2 Sulforaphane (mainly Broccoli)
1 Berbamine
1 Ginkgetin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:32  Cells:%  prod#:%  Target#:352  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page